No trials match your search ""

• Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

  Stanford is currently accepting patients for this trial.

• Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

  Stanford is currently accepting patients for this trial.

• Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

  Stanford is currently accepting patients for this trial.

• Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors

  Stanford is currently accepting patients for this trial.

• Phase 2 Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

  Stanford is currently accepting patients for this trial.

• LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy

  Stanford is currently accepting patients for this trial.

• An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

  Stanford is currently accepting patients for this trial.

• Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

  Stanford is currently accepting patients for this trial.

• Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

  Stanford is currently accepting patients for this trial.

• Study of Infigratinib in Combination With Tamoxifen or With Fulvestrant and Palbociclib in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

  Stanford is currently accepting patients for this trial.

• CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

  Stanford is currently accepting patients for this trial.

• A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

  Stanford is currently accepting patients for this trial.

• A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

  Stanford is currently accepting patients for this trial.

• Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

  Stanford is currently accepting patients for this trial.

• Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

  Stanford is currently accepting patients for this trial.

• A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

  Stanford is currently accepting patients for this trial.

• A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

  Stanford is currently accepting patients for this trial.

• Trial of Acebilustat for the Treatment of Upper Arm Lymphedema

  Stanford is currently accepting patients for this trial.

• De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  Stanford is currently accepting patients for this trial.

• Previous
• 1
• 2
• Next

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

• International Lymphatic Disease and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

No trials match your search ""

• Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

  Stanford is currently accepting patients for this trial.

• Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

  Stanford is currently accepting patients for this trial.

• Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer

  Stanford is currently accepting patients for this trial.

• Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Study

  Stanford is currently accepting patients for this trial.

• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

  Stanford is currently accepting patients for this trial.

• Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma

  Stanford is currently accepting patients for this trial.

• A Study of AL102 in Patients With Progressing Desmoid Tumors

  Stanford is currently accepting patients for this trial.

• Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors

  Stanford is currently accepting patients for this trial.

• Detection of Immune Changes as a Result of Surgical Trauma in Human Subject

  Stanford is currently accepting patients for this trial.